Mart van de Laar, MD, PhD (he/him/his)

University of Twente
HENGELO OV, Netherlands

MD and PhD obtained at University of Amsterdam. Fully trained in Internal Medicine and Rheumatology. Ritered as consultant. Active interst in clinical research as well as in organisation and finance of healthcare based upon clinical- and patient reported outcomes.

Presentation(s):

• 0450: Baricitinib versus TNF-inhibitors in Patients with Active Rheumatoid Arthritis After Failure of CsDMARDs: A Pragmatic, Multicenter, Real-Life Study in a Treat-to-Target Setting

  Sunday, November 12, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.